For Healthcare Professionals Only.
GASTROClear™ is the world’s first molecular blood test approved for use in early detection of stomach cancer. The GASTROClear test detects multiple microRNA (miRNA) biomarkers associated with gastric cancer. The quantities of 12 miRNAs are measured to provide an additive association with gastric cancer. The result from the test may indicate the presence of gastric cancer, in which case the patient should then go for gastroscopy and biopsy as required. The output of the GASTROClear test is a risk score, where a high score may indicate the presence of gastric cancer and should be followed up by gastroscopy.
Login to read more
